Clinical usefulness of E4-phytohemagglutinin reactive C4-binding protein relative front value in serum for distinguishing between ovarian clear cell adenocarcinoma and endometrioma
Serum E4-phytohemagglutinin-reactive C4BP relative front value was significantly higher in ovarian clear cell adenocarcinoma than in controls and aided differentiation from endometrioma, especially when combined with HE4.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (28)
- Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review via openalex
- Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma via openalex
- Diagnostic performance of CA 125, HE4, and risk of Ovarian Malignancy Algorithm for ovarian cancer via openalex
- Endometrioid adenocarcinoma of the ovary and endometriosis via openalex
- Endometriosis-Associated Ovarian Cancer: Population Characteristics and Prognosis via openalex
- Fully-sialylated alpha-chain of complement 4-binding protein: Diagnostic utility for ovarian clear cell carcinoma via openalex
- doi:10.3802/jgo.2020.31.e45 via openalex
- W1526464509 via openalex
- doi:10.1002/bmc.4180 via openalex
- doi:10.1016/s0021-9258(17)37231-9 via openalex
- doi:10.1016/j.ab.2009.02.030 via openalex
- W6631469649 via openalex
- W6761811105 via openalex
- doi:10.1056/nejm198310133091503 via openalex
- doi:10.3390/cancers12123730 via openalex
- doi:10.1007/s13277-014-2738-7 via openalex
- doi:10.1016/s0020-7292(06)60033-7 via openalex
- doi:10.1002/(sici)1097-0134(19980601)31:4<391::aid-prot6>3.0.co;2-l via openalex
- doi:10.1016/0009-8981(93)90297-h via openalex
- doi:10.1016/s0021-9258(19)83586-x via openalex
- doi:10.1111/his.12033 via openalex
- doi:10.1016/0009-8981(96)06369-3 via openalex
- doi:10.1016/0076-6879(89)79112-6 via openalex
- doi:10.1006/gyno.1994.1179 via openalex
- doi:10.1007/s10147-021-01914-y via openalex
- doi:10.7150/jca.61107 via openalex
- doi:10.1093/oxfordjournals.jbchem.a122972 via openalex
- doi:10.1159/000479006 via openalex
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-10-11T09:27:45.537177+00:00
- openalex
- last seen: 2026-05-11T06:51:41.386625+00:00
- pubmed
- last seen: 2026-10-13T06:07:10.018355+00:00
- unpaywall
- last seen: 2026-10-13T06:25:51.201866+00:00